Early Detection of Cancer research hub

PATHFINDER 2: A Multi-Cancer Early Detection Study

The PATHFINDER 2 study is looking at a new blood test called the GRAIL multi-cancer early detection (MCED) test. This test aims to find many types of cancer early. It's for people aged 50 and over in North America who already get regular cancer screenings.